Us Bancorp \De\ Haemonetics Corp Transaction History

Us Bancorp \De\

$75.6 Billion
Q4 2024

A detailed history of Us Bancorp \De\ transactions in Haemonetics Corp stock. As of the latest transaction made, Us Bancorp \De\ holds 583 shares of HAE stock, worth $37,451. This represents 0.0% of its overall portfolio holdings.

Number of Shares

583

Previous 451 29.27%

Holding current value

$37,451

Previous $36,000 25.0%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 05, 2025	BUY	$71.16 - $93.38 $9,393 - $12,326	132 Added 29.27%	583 $45,000
Q3 2024 Oct 28, 2024	SELL	$72.45 - $91.58 $2,898 - $3,663	-40 Reduced 8.15%	451 $36,000
Q2 2024 Aug 06, 2024	SELL	$81.24 - $97.37 $1,462 - $1,752	-18 Reduced 3.54%	491 $40,000
Q1 2024 May 07, 2024	SELL	$71.24 - $85.35 $14,746 - $17,667	-207 Reduced 28.91%	509 $43,000
Q4 2023 Feb 09, 2024	BUY	$80.59 - $92.61 $3,062 - $3,519	38 Added 5.6%	716 $61,000
Q3 2023 Nov 03, 2023	SELL	$82.56 - $93.49 $3,137 - $3,552	-38 Reduced 5.31%	678 $60,000
Q2 2023 Aug 09, 2023	SELL	$80.84 - $89.45 $5,820 - $6,440	-72 Reduced 9.14%	716 $60,000
Q1 2023 May 09, 2023	SELL	$72.75 - $90.6 $2,691 - $3,352	-37 Reduced 4.48%	788 $65,000
Q4 2022 Feb 13, 2023	SELL	$73.85 - $86.14 $14,474 - $16,883	-196 Reduced 19.2%	825 $64,000
Q3 2022 Oct 27, 2022	SELL	$63.3 - $78.66 $21,205 - $26,351	-335 Reduced 24.71%	1,021 $76,000
Q2 2022 Aug 01, 2022	SELL	$49.27 - $66.08 $30,892 - $41,432	-627 Reduced 31.62%	1,356 $88,000
Q1 2022 May 11, 2022	SELL	$43.77 - $63.22 $11,511 - $16,626	-263 Reduced 11.71%	1,983 $126,000
Q4 2021 Feb 11, 2022	SELL	$49.55 - $74.59 $52,919 - $79,662	-1,068 Reduced 32.23%	2,246 $119,000
Q3 2021 Nov 10, 2021	BUY	$57.6 - $70.59 $37,958 - $46,518	659 Added 24.82%	3,314 $233,000
Q2 2021 Aug 05, 2021	BUY	$51.81 - $118.56 $4,300 - $9,840	83 Added 3.23%	2,655 $176,000
Q1 2021 Apr 28, 2021	SELL	$111.01 - $139.48 $3,441 - $4,323	-31 Reduced 1.19%	2,572 $285,000
Q4 2020 Feb 04, 2021	SELL	$88.75 - $119.95 $7,543 - $10,195	-85 Reduced 3.16%	2,603 $309,000
Q3 2020 Nov 10, 2020	SELL	$75.65 - $93.58 $13,768 - $17,031	-182 Reduced 6.34%	2,688 $234,000
Q2 2020 Aug 07, 2020	SELL	$84.96 - $118.91 $57,602 - $80,620	-678 Reduced 19.11%	2,870 $258,000
Q1 2020 May 13, 2020	BUY	$74.34 - $121.82 $24,903 - $40,809	335 Added 10.43%	3,548 $354,000
Q4 2019 Feb 04, 2020	SELL	$114.37 - $129.46 $6,633 - $7,508	-58 Reduced 1.77%	3,213 $370,000
Q3 2019 Nov 08, 2019	SELL	$117.16 - $138.52 $820 - $969	-7 Reduced 0.21%	3,271 $412,000
Q2 2019 Aug 13, 2019	BUY	$81.74 - $120.34 $12,996 - $19,134	159 Added 5.1%	3,278 $394,000
Q1 2019 May 08, 2019	SELL	$83.25 - $102.12 $110,389 - $135,411	-1,326 Reduced 29.83%	3,119 $273,000
Q4 2018 Feb 13, 2019	SELL	$90.66 - $116.63 $211,600 - $272,214	-2,334 Reduced 34.43%	4,445 $445,000
Q3 2018 Nov 01, 2018	SELL	$89.96 - $114.58 $345,536 - $440,101	-3,841 Reduced 36.17%	6,779 $777,000
Q2 2018 Aug 08, 2018	SELL	$71.53 - $95.75 $641,051 - $858,111	-8,962 Reduced 45.77%	10,620 $952,000
Q1 2018 May 08, 2018	SELL	$60.72 - $74.41 $127,633 - $156,409	-2,102 Reduced 9.69%	19,582 $1.43 Million
Q4 2017 Feb 02, 2018	SELL	$44.96 - $58.99 $105,386 - $138,272	-2,344 Reduced 9.76%	21,684 $1.26 Million
Q3 2017 Nov 13, 2017	BUY	$40.38 - $44.87 $970,250 - $1.08 Million	24,028	24,028 $1.08 Million

Others Institutions Holding HAE

# of Institutions

348

Shares Held

55.7M

Call Options Held

600K

Put Options Held

474K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.3B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account